etoposide has been researched along with Peritoneal Neoplasms in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (11.67) | 18.7374 |
1990's | 18 (30.00) | 18.2507 |
2000's | 21 (35.00) | 29.6817 |
2010's | 13 (21.67) | 24.3611 |
2020's | 1 (1.67) | 2.80 |
Authors | Studies |
---|---|
Goya, K; Iida, T; Kuriyama, Y; Maeda, H; Manabe, T; Mikami, M; Miyatake, N; Muramatsu, T; Nakajima, R; Narayama, C; Narayama, T; Oiwa, I | 1 |
Angelini, P; Cecil, T; Chisholm, JC; Dayal, S; Okoye, B; Sjoberg Bexelius, T | 1 |
Ben Hassouna, J; Bouzaiene, H; Ghalleb, M; Hadiji, A; Hechiche, M; Rahal, K; Slim, S | 1 |
Cuadra, M; Lapuente-Ocamica, O; Lete, I; Lopez-Picado, A; Maestro, L; Ugarte, L | 1 |
Boulinguez, S; Evrard, SM; Godeau, M; Guinard, E; Lamant, L; Larrieu-Ciron, D; Meyer, N; Pages-Laurent, C; Riffaud, L; Severino-Freire, M; Sibaud, V; Tauber, M | 1 |
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C | 1 |
Jaśkowski, P; Krzanowska, K; Krzanowski, M; Miarka, P; Sułowicz, W | 1 |
Chang, TC; Chiang, YC; Hung, YC; Lai, HC; Lin, H; Liou, WS; Lu, CH; Sun, HD; Wang, KL; Wang, PH | 1 |
Hoskins, P; Kumar, A; Le, N; Santos, J | 1 |
Balasubramaniam, S; Bates, SE; Edgerly, M; Fojo, T; Leuva, H; Litman, T; Merino, MJ; Payabyab, EC; Velarde, M; Venkatesan, AM | 1 |
Kim, SW; Lim, MC; Park, JH; Park, JY; Park, SY; Yoo, CW | 1 |
Ast, A; Buhrmann, C; Du Bois, A; Glaser, F; Harter, P; Hirsch, T; Kasenda, B | 1 |
Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES | 1 |
Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK | 1 |
Hwang, JH; Kang, S; Lim, MC; Park, SY; Seo, SS; Yoo, HJ | 1 |
Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D | 1 |
Akiyama, H; Kunisaki, C; Matsuda, G; Nomura, M; Ono, H; Otsuka, Y; Shimada, H | 1 |
Hosoya, Y; Kaneko, Y; Koinuma, K; Nagai, H; Saito, K; Yasuda, Y | 1 |
Cowlishaw, D; McKendrick, JJ; Mead, GM | 1 |
Fisher, C; Hemmings, C | 1 |
Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M | 1 |
Buller, RE; Geisler, JP; Lush, R; Sanders, L; Shahin, MS; Sood, AK; Sorosky, JI; Sullivan, D | 1 |
Eimermacher, A; Flieger, D; Galle, PR; Geer, T; Gracien, E; Heike, M; Höhler, T; Junginger, T; Menges, M; Moehler, M; Siebler, J; Wein, A | 1 |
Akazawa, Y; Isomoto, H; Kohno, S; Mizuta, Y; Nakagoe, T; Ohara, H; Ohba, K; Ohnita, K; Omagari, K; Shiozawa, K; Shirono, K; Takeshima, F; Tanaka, K; Yasutake, T | 1 |
Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Murakami, N; Shirouzu, K; Yano, S | 1 |
Hirono, Y; Iida, A; Katayama, K; Murakami, M; Yamaguchi, A | 1 |
Anastasiadis, AG; Argyropoulou, P; Bourikas, G; Kaloutsi, V; Margaritis, D; Pantelidou, D; Prassopoulos, P; Tsatalas, C | 1 |
Bell, JG; Fusco, NL; Markman, M; Rose, PG | 1 |
Bakhshi, S; Karak, AK; Singh, D; Thulkar, S | 1 |
Aydin, Y; Cicin, I; Eralp, Y; Ozluk, Y; Saip, P; Selam, M; Topuz, E; Topuz, S | 1 |
Fujimura, T; Fujita, H; Fushida, S; Hirono, Y; Itoh, H; Kaji, M; Kinami, S; Nakagawara, H; Nakai, M; Yonemura, Y | 1 |
Maasilta, P; Mäntylä, M; Mattson, K; Salo, J; Tammilehto, L | 1 |
Hagiwara, A; Itoh, M; Lee, JS; Muranishi, S; Sasabe, T; Takahashi, T; Tashima, S; Yoneyama, C | 1 |
Jibiki, M; Kusano, H; Matsuo, T; Miura, T; Miyashita, K; Nakagoe, T; Tomita, M | 1 |
Chen, SC; Curtin, J; Groshen, S; Jeffers, S; Morrow, CP; Muggia, FM; Russell, C; Schlaerth, J | 1 |
Bagchi, P; Catalano, R; Comis, RL; Hogan, M; LaCreta, FP; Langer, CJ; Nash, S; O'Dwyer, PJ; Rosenblum, N | 1 |
Culine, S; Droz, JP; Duvillard, P; Farhat, F; Lhommé, C; Michel, G; Schreinerova, M; Soulié, P; Terrier-Lacombe, MJ; Théodore, C | 1 |
Sakata, Y; Tsushima, K | 1 |
Amano, T; Hatori, S; Imada, T; Ito, H; Kondo, J; Maehara, T; Rino, Y; Shiozawa, M; Suzuki, Y; Takahashi, M | 1 |
Asano, T; Hayakawa, M; Ikeda, Y; Kuruma, H; Miyajima, A; Nakajima, F; Nakamura, H | 1 |
Matsumoto, K; Mishima, M; Nakagawa, S; Onda, T; Taketani, Y; Yamada, M; Yasugi, T; Yoshikawa, H | 1 |
Kang, SB; Lee, HP; Park, IA; Park, NH; Ryu, SY | 1 |
Hirose, K; Iida, A; Katayama, K; Kusaka, Y; Nakagawara, G; Umeda, S; Yamaguchi, A | 1 |
Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S | 1 |
Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
Iwahashi, K; Kitaoka, Y; Sakurai, N; Shiraishi, S; Tanaka, Y | 1 |
Fusco, N; Greer, B; McGuire, W; Rodriguez, M; Rose, PG; Walker, J | 1 |
Furukawa, Y; Imanishi, H; Kouzuma, T; Nozawa, T; Sato, K; Sato, T; Yanagihara, M | 1 |
Hagiwara, A; Ito, M; Lee, M; Muranishi, S; Sakakura, C; Sasabe, T; Shoubayashi, S; Takahashi, T; Tashima, S | 1 |
Adachi, N; Fujii, T; Haraguchi, M; Komatsu, T; Kurihara, N; Nakaoka, Y; Ota, K | 1 |
Braly, PS; Howell, SB; Isonishi, S; Kim, S; Kirmani, S; McClay, EF; Plaxe, SC | 1 |
Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP; Plusquellec, Y; Roche, H | 1 |
Fujita, H; Ito, R; Okada, H; Yamamoto, T | 1 |
Goel, R; Howell, SB; Kirmani, S | 1 |
Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 1 |
Aikou, T; Hokita, S; Maenohara, S; Shimazu, H; Takao, S; Tokushige, M | 1 |
Aoyagi, H; Fujii, T; Izuo, M; Miyamoto, Y; Ohwada, S; Takeshita, M; Tanahasi, Y; Uchida, O | 1 |
Nagasue, N; Nishida, T; Obuchi, T; Sasaki, T; Yakushiji, M | 1 |
Eisenhauer, EA; Evans, WK; Kocha, W; Murray, N; Wierzbicki, R; Wilson, K | 1 |
Andrews, PA; Cleary, SM; Horton, C; Howell, SB; Kim, S; Lucas, WE; Markman, M; Schiefer, MA; Weiss, RJ; Zimm, S | 1 |
5 review(s) available for etoposide and Peritoneal Neoplasms
Article | Year |
---|---|
Growing teratoma syndrome after ovarian inmature teratoma: a case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease Progression; Douglas' Pouch; Etoposide; Female; Humans; Hysterectomy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Grading; Neoplasm, Residual; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Reoperation; Salpingectomy; Syndrome; Teratoma; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Primary yolk sac tumor of the omentum: a case report and review of the literature.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Fallopian Tubes; Female; Histocytochemistry; Humans; Keratins; Lymph Node Excision; Omentum; Ovariectomy; Peritoneal Neoplasms; Peritoneum; Tomography, X-Ray Computed | 2009 |
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation | 2012 |
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Pancreatic Ductal; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2005 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
14 trial(s) available for etoposide and Peritoneal Neoplasms
Article | Year |
---|---|
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2010 |
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Thrombocytopenia; Treatment Outcome | 2012 |
[Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Prognosis; Regression Analysis; Stomach Neoplasms | 2002 |
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chromatography, High Pressure Liquid; Disease Progression; DNA; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Recurrence; Time Factors; Topotecan; Treatment Outcome | 2004 |
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Levoleucovorin; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2005 |
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Topotecan | 2006 |
Oral etoposide in the treatment of malignant mesothelioma. A phase II study.
Topics: Administration, Oral; Adult; Aged; Etoposide; Female; Humans; Male; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Remission Induction | 1994 |
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome | 1996 |
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Hot Temperature; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Peritoneal Cavity; Peritoneal Neoplasms; Proportional Hazards Models; Stomach Neoplasms; Treatment Outcome | 1999 |
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia | 2000 |
A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Liposomes; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms | 2002 |
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Peritoneal Neoplasms | 1991 |
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Injections, Intraperitoneal; Leukemia P388; Leukopenia; Male; Mice; Middle Aged; Peritoneal Neoplasms; Podophyllotoxin; Remission Induction; Teniposide | 1991 |
41 other study(ies) available for etoposide and Peritoneal Neoplasms
Article | Year |
---|---|
A Case of Recurrent Peritoneal Cancer in Which an Antitumor Effect Was Obtained Using a Combination of Etoposide and a Chinese Herbal Medicine with Maintenance of Daily Life.
Topics: Activities of Daily Living; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Drugs, Chinese Herbal; Etoposide; Female; Humans; Membrane Proteins; Middle Aged; Peritoneal Neoplasms; Treatment Outcome | 2019 |
Hyperthermic intraperitoneal chemotherapy (HIPEC) as another treatment modality for desmoplastic round cell tumour patients: first paediatric experience from UK.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Cytoreduction Surgical Procedures; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Humans; Hyperthermic Intraperitoneal Chemotherapy; Ifosfamide; Liver Neoplasms; Maintenance Chemotherapy; Neoadjuvant Therapy; Pelvic Neoplasms; Peritoneal Neoplasms; Radiotherapy; Remission Induction; United Kingdom; Vincristine; Vinorelbine | 2021 |
Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Young Adult | 2017 |
A case of merkel leptomeningeal evolution after complete remission upon anti-PD-1 treatment.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Humans; Lower Extremity; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Nivolumab; Peritoneal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms | 2019 |
[Patient receiving peritoneal dialysis after treatment of ovarian cancer].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Tubules; Ovarian Neoplasms; Peritoneal Dialysis; Peritoneal Neoplasms; Renal Insufficiency, Chronic | 2014 |
Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulosa Cell Tumor; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taiwan; Young Adult | 2015 |
Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer: An Analysis of Outcomes Obtained With Oral Etoposide.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Salvage Therapy; Survival Rate | 2018 |
Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Laparoscopy; Mitotane; Peritoneal Neoplasms; Retrospective Studies | 2016 |
Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Peritoneal Neoplasms; Young Adult | 2009 |
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2011 |
A case of aggressive neuroendocrine carcinoma of the stomach.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Omentum; Pancreatic Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2003 |
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Peritoneal Neoplasms; Teratoma; Testicular Neoplasms | 2003 |
Primary omental synovial sarcoma: a case with cytogenetic confirmation.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Maternal Age; Mesna; Neoplasm Recurrence, Local; Omentum; Peritoneal Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, High-Risk; Sarcoma, Synovial | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Etoposide; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
[Peritoneal dissemination of scirrhous type 4 gastric cancers].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Etoposide; Female; Gastrectomy; Humans; Immunotherapy; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Survival Rate; Tegafur | 2005 |
[Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Hyperthermia, Induced; Infusions, Parenteral; Mitomycins; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms | 2005 |
Successful treatment of lymph node extramedullary plasmacytoma with bortezomib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Injections, Intravenous; Lymph Nodes; Male; Middle Aged; Peritoneal Neoplasms; Plasmacytoma; Pyrazines; Radiotherapy Dosage; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous | 2006 |
Childhood primary mesenteric seminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Humans; Male; Mesentery; Peritoneal Neoplasms; Seminoma | 2006 |
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate | 2008 |
[Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Perfusion; Peritoneal Lavage; Peritoneal Neoplasms; Peritoneum; Peritonitis; Stomach Neoplasms | 1995 |
Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis.
Topics: Animals; Body Weight; Bone Marrow; Dose-Response Relationship, Drug; Drug Carriers; Etoposide; Injections, Intraperitoneal; Iodine; Iodized Oil; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Peritoneal Neoplasms; Sesame Oil; Water | 1995 |
[Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Thiosulfates | 1993 |
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Creatinine; Cyclophosphamide; Epithelium; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Kidney; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Treatment Outcome | 1993 |
Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Parenteral; Male; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Survival Analysis; Treatment Outcome | 1993 |
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Drug Combinations; Etoposide; Female; Humans; Mesothelioma; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[Intraperitoneal dissemination of testicular tumor: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Peritoneal Neoplasms; Seminoma; Testicular Neoplasms | 1998 |
Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pelvis; Peritoneal Neoplasms; Prognosis; Survival Rate | 1998 |
Primary endodermal sinus tumor of the omentum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Female; Humans; Middle Aged; Omentum; Peritoneal Neoplasms | 1999 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
[A case of pseudomyxoma peritonei treated successfully with intraperitoneal administration of CBDCA and etoposide, followed by local delivery of dextran with CDDP during surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cystadenoma, Mucinous; Dextrans; Etoposide; Female; Humans; Hysterectomy; Injections, Intraperitoneal; Intraoperative Care; Laparotomy; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2001 |
[Effectiveness of prolonged oral administration of low-dose etoposide in a case of malignant lymphoma in the mesenterium].
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Follicular; Mesentery; Peritoneal Neoplasms; Prednisolone; Vincristine | 2002 |
Etoposide microcrystals suspended in oil: a new dosage form to peritoneal carcinomatosis in mice.
Topics: Animals; Carcinoma; Chemistry, Pharmaceutical; Etoposide; Injections, Intraperitoneal; Leukemia P388; Male; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasm Transplantation; Oils; Peritoneal Neoplasms; Suspensions | 1992 |
[A case of small cell carcinoma of the lung responding well to oral etoposide therapy].
Topics: Administration, Oral; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Peritoneal Neoplasms | 1991 |
[A case of recurrent ovarian cancer markedly responding to daily oral administration of low dose etoposide].
Topics: Administration, Oral; Aged; Cystadenocarcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Remission Induction | 1990 |
Novel approaches to intraperitoneal drug delivery.
Topics: Antineoplastic Agents; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Long-Term Care; Methotrexate; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Mitoxantrone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms | 1989 |
[Intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis using totally implantable peritoneal access system].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Male; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Stomach Neoplasms | 1989 |
[Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms | 1989 |
Extragenital malignant mixed Müllerian tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peritoneal Neoplasms | 1988 |
A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Pleural Neoplasms | 1988 |
Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
Topics: Abdomen; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation; Etoposide; Female; Humans; Kinetics; Male; Middle Aged; Pain; Peritoneal Cavity; Peritoneal Neoplasms | 1987 |